Polyplus

Polyplus is a leading upstream solutions provider for advanced biologic and cell and gene therapy production from research to commercial scale. An innovator in nucleic acid delivery, the legacy portfolio features process-centric transfection reagents, kits, and support services. Custom plasmid vector design was integrated into the offer in 2022 as a first measure to expanding the products and services portfolio to help customers (or the industry) optimize process economics while meeting strict scientific and regulatory standards. Headquartered in Europe, the Polyplus team continues to grow globally with operations in the United States and Asia

Research; dna; transfection; gene expression; bioproduction; life sciences; biotechnology; rna interference; science; biology; protein production; virus production; cell culture; crispr; and biotechnology

Polyplus operates in the Biotechnology research industry.

Polyplus's revenue is 11m - 100m

Polyplus has 51 - 200 employees.